Phio is a Massachusetts-based clinical-stage biotechnology company that researches and develops RNAi therapies for the treatment of cancer... Read more
Phio is a Massachusetts-based clinical-stage biotechnology company that researches and develops RNAi therapies for the treatment of cancer... Read more
President & CEO
Robert Bitterman
2011
PublicIndependent CompanyNASDAQPHIO
News
Funding
Jan 22, 2025
FinanzNachrichten
Phio Pharmaceuticals received $1.8M in Post-IPO Equity Funding
Conference Presentation
Oct 16, 2024
FinanzNachrichten
Phio Pharmaceuticals Corp.: Phio Pharmaceuticals Presenting Data on Its INSTAYL Compound PH-894 at ASGCT's 2024 Advancing Gene and Cell Therapies for Cancer Conference
